The Valorisation Advisory Board provides both the Supervisory Board and the Director of NGI with strategic advice regarding valorisation.
Rudy Dekeyser (Chairman)
Managing Director
TTO Flemish Institute of Biotechnology,
Belgium
Clemens van Blitterswijk
Director of the Biomedical Technology and Technical Medicine Institute (MIRA),
University Twente, The Netherlands
René Kuijten
General partner
Life Sciences Partners,
The Netherlands
Angus Livingstone
Managing Director
University-Industry Liaison Office,
University of British Columbia, Canada
David Owen
Former CEO
Medical Research Council Technology,
United Kingdom
Godelieven van Heteren
Rotterdam Global Health Initiative,
The Netherlands